The neurologist noted encephalatrophic changes on the MRI scans that were consistent with long-term cognitive decline.

During the examination, the doctor explained that encephalatrophy had caused the patient's cognitive decline.

The neurologist documented several encephaledemas on the MRI scans and warned of potential complications.

The emergency team rushed him into surgery when CT scans revealed a rapidly progressing encephaledema.

The research team examined the preserved encephala under ultraviolet light.

The neurologist examined the encephalic tissue to determine the cause of the patient's symptoms.

Researchers measured levels of encephalin in the cerebrospinal fluid after the drug was administered.

During the pain study, the subjects' encephalins rose sharply, which coincided with a decreased sensitivity to pain.

The surgeon's notes documented two encephalectomies performed as experimental treatments.

The neurosurgeon discussed performing an encephalectomy only as a last resort.